{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:29:26Z","timestamp":1793384966568,"version":"4.5.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The post-myocardial infarction heart failure (HF) still carries a huge burden since current therapy is unsuccessful to abrogate poor prognosis. Thus, new approaches are needed, and photobiomodulation therapy (PBMt)\u00a0may be a way. However, it is not known whether PBMt added to a standard HF therapy provides additional improvement in cardiac remodeling in infarcted rats. This study sought to determine the combined carvedilol-drug and PBMt with low-level laser therapy value in HF. Rats with large infarcts were treated for 30 days. The functional fitness was evaluated using a motorized treadmill. Echocardiography and hemodynamic measurements were used for functional evaluations of left ventricular (LV). ELISA, Western blot and biochemical assays were used to evaluate inflammation and oxidative stress in the myocardium. Carvedilol and PBMt had a similar action in normalizing pulmonary congestion and LV end-diastolic pressure, attenuating LV dilation, and improving LV systolic function. Moreover, the application of PBMt\u00a0to carvedilol-treated rats inhibited myocardial hypertrophy and improved +dP\/dt of LV. PBMt alone prevented inflammation with a superior effect than carvedilol. Carvedilol and PBMt\u00a0normalized 4-hydroxynonenal (a lipoperoxidation marker) levels in the myocardium. However, importantly, the addition of PBMt to carvedilol attenuated oxidized protein content and triggered a high activity of the anti-oxidant catalase enzyme. In conclusion, these data show that the use of PBMt plus carvedilol therapy results in a significant additional improvement in HF in a rat model of myocardial infarction. These beneficial effects were observed to be due, at least in part, to decreased myocardial inflammation and oxidative stress.<\/jats:p>","DOI":"10.1038\/s41598-019-46021-1","type":"journal-article","created":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T10:03:09Z","timestamp":1561975389000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Photobiomodulation therapy combined with carvedilol attenuates post-infarction heart failure by suppressing excessive inflammation and oxidative stress in rats"],"prefix":"10.1038","volume":"9","author":[{"given":"Vanessa","family":"Grandinetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando Pereira","family":"Carlos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ednei Luiz","family":"Antonio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helenita Antonia","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Felipe Neves","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Yoshizaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara Sampaio Dias Martins","family":"Mansano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fl\u00e1vio Andr\u00e9","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie Andrews","family":"Porte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianna M\u00f3es","family":"Albuquerque-Pontes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo de Tarso Camillo","family":"de Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha Trindade","family":"Manchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernesto Cesar","family":"Leal-Junior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo Jos\u00e9 Ferreira","family":"Tucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrey Jorge","family":"Serra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,1]]},"reference":[{"key":"46021_CR1","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.ijcard.2016.10.060","volume":"227","author":"M Metra","year":"2017","unstructured":"Metra, M., Carubelli, V., Ravera, A. & Stewart Coats, A. J. Heart failure 2016: still more questions than answers. Int. J. Cardiol. 227, 766\u2013777 (2017).","journal-title":"Int. J. Cardiol."},{"key":"46021_CR2","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1136\/heartjnl-2015-307855","volume":"102","author":"H Bulluck","year":"2016","unstructured":"Bulluck, H., Yellon, D. M. & Hausenloy, D. J. Reducing myocardial infarct size: challenges and future opportunities. Heart. 102, 341\u201334 (2016).","journal-title":"Heart."},{"key":"46021_CR3","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/164_2017_24","volume":"243","author":"L Papadimitriou","year":"2017","unstructured":"Papadimitriou, L., Hamo, C. E. & Butler, J. Heart failure guidelines on pharmacotherapy. Handb. Exp. Pharmacol. 243, 109\u2013129 (2017).","journal-title":"Handb. Exp. Pharmacol."},{"key":"46021_CR4","doi-asserted-by":"publisher","first-page":"e101270","DOI":"10.1371\/journal.pone.0101270","volume":"9","author":"MT Manchini","year":"2014","unstructured":"Manchini, M. T. et al. Amelioration of cardiac function and activation of anti-inflammatory vasoactive peptides expression in the rat myocardium by low level laser therapy. PLoS One 9, e101270 (2014).","journal-title":"PLoS One"},{"key":"46021_CR5","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3389\/fphys.2017.00023","volume":"8","author":"MT Manchini","year":"2017","unstructured":"Manchini, M. T. et al. Low-level laser application in the early myocardial infarction stage has no beneficial role in heart failure. Front. Physiol. 8, 23 (2017).","journal-title":"Front. Physiol."},{"key":"46021_CR6","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1089\/pho.2015.3988","volume":"34","author":"A Blatt","year":"2016","unstructured":"Blatt, A. et al. Low-level laser therapy to the bone marrow reduces scarring and improves heart function post-acute myocardial infarction in the pig. Photomed. Laser Surg. 34, 516\u2013524 (2016).","journal-title":"Photomed. Laser Surg."},{"key":"46021_CR7","first-page":"1109","volume":"15","author":"FP Carlos","year":"2016","unstructured":"Carlos, F. P. et al. Role of low-level laser therapy on the cardiac remodeling after myocardial infarction: A systematic review of experimental studies. Life Sci. 15, 1109\u2013114 (2016).","journal-title":"Life Sci."},{"key":"46021_CR8","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1177\/107424840400900207","volume":"9","author":"JL Bauman","year":"2004","unstructured":"Bauman, J. L. & Talbert, R. L. Pharmacodynamics of beta-blockers in heart failure: lessons from the carvedilol or metoprolol European trial. J. Cardiovasc. Pharmacol. Ther. 9, 117\u2013128 (2004).","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"46021_CR9","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1124\/jpet.112.196915","volume":"343","author":"F Hassan","year":"2012","unstructured":"Hassan, F. et al. Carvedilol enhances mesenchymal stem cell therapy for myocardial infarction via inhibition of caspase-3 expression. J. Pharmacol. Exp. Ther. 343, 62\u201371 (2012).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"46021_CR10","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.ijcard.2005.08.065","volume":"111","author":"B Li","year":"2006","unstructured":"Li, B. et al. Effects of carvedilol on cardiac cytokines expression and remodeling in rat with acute myocardial infarction. Int. J. Cardiol. 111, 247\u2013255 (2006).","journal-title":"Int. J. Cardiol."},{"key":"46021_CR11","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/j.1527-5299.2002.00718.x","volume":"8","author":"WM Book","year":"2002","unstructured":"Book, W. M. Carvedilol: a nonselective beta blocking agent with antioxidant properties. Congest Heart Fail 8, 173\u2013177 (2002).","journal-title":"Congest Heart Fail"},{"key":"46021_CR12","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1093\/eurjhf\/hfr017","volume":"13","author":"MF Piepoli","year":"2011","unstructured":"Piepoli, M. F. et al. Exercise training in heart failure: from theory to practice. A consensus document of the heart failure association and the european association for cardiovascular prevention and rehabilitation. Eur. J. Heart Fail. 13, 347\u2013357 (2011).","journal-title":"Eur. J. Heart Fail."},{"key":"46021_CR13","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/S0300-8932(04)77241-3","volume":"57","author":"P Castro","year":"2004","unstructured":"Castro, P. et al. Effects of carvedilol on functional capacity, left ventricular function, catecholamines, and oxidative stress in patients with chronic heart failure. Rev. Esp. Cardiol. 57, 1053\u20131058 (2004).","journal-title":"Rev. Esp. Cardiol."},{"key":"46021_CR14","doi-asserted-by":"publisher","first-page":"55L","DOI":"10.1016\/S0002-9149(97)00849-7","volume":"80","author":"MB Fowler","year":"1997","unstructured":"Fowler, M. B. Effects of beta blockers on symptoms and functional capacity in heart failure. Am. J. Cardiol. 80, 55L\u201358L (1997).","journal-title":"Am. J. Cardiol."},{"key":"46021_CR15","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1007\/s10103-016-1922-y","volume":"31","author":"L Capalonga","year":"2016","unstructured":"Capalonga, L. et al. Light-emitting diode therapy (LEDT) improves functional capacity in rats with heart failure. Lasers Med. Sci. 31, 937\u2013944 (2016).","journal-title":"Lasers Med. Sci."},{"key":"46021_CR16","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1097\/HCR.0000000000000145","volume":"36","author":"G Tzanis","year":"2016","unstructured":"Tzanis, G. et al. Attenuated microcirculatory response to maximal exercise in patients with chronic heart failure. J. Cardiopulm. Rehabil. Prev. 36, 33\u201337 (2016).","journal-title":"J. Cardiopulm. Rehabil. Prev."},{"key":"46021_CR17","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1161\/01.CIR.103.2.296","volume":"103","author":"U Oron","year":"2001","unstructured":"Oron, U. et al. Low-energy laser irradiation reduces formation of scar tissue after myocardial infarction in rats and dogs. Circulation. 103, 296\u2013301 (2001).","journal-title":"Circulation."},{"key":"46021_CR18","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0167-5273(01)00503-4","volume":"80","author":"N Ad","year":"2001","unstructured":"Ad, N. & Oron, U. Impact of low level laser irradiation on infarct size in the rat following myocardial infarction. Int J Cardiol. 80, 109\u2013116 (2001).","journal-title":"Int J Cardiol."},{"key":"46021_CR19","first-page":"86","volume":"5","author":"N Kazemi Khoo","year":"2014","unstructured":"Kazemi Khoo, N., Babazadeh, K., Lajevardi, M., Dabaghian, F. H. & Mostafavi, E. Application of low-level laser therapy following coronary artery bypass grafting (CABG) surgery. J Lasers Med Sci. 5, 86\u201391 (2014).","journal-title":"J Lasers Med Sci."},{"key":"46021_CR20","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.ejheart.2008.06.007","volume":"10","author":"C Stumpf","year":"2008","unstructured":"Stumpf, C. et al. Interleukin-10 improves left ventricular function in rats with heart failure subsequent to myocardial infarction. Eur. J. Heart Fail. 10, 733\u2013739 (2008).","journal-title":"Eur. J. Heart Fail."},{"key":"46021_CR21","doi-asserted-by":"crossref","unstructured":"van der Pol, A., van Gilst, W. H., Voors, A. A. & van der Meer, P. Treating oxidative stress in heart failure: past, present and future.\u00a0Eur J Heart Fail.\u00a021, 425\u2013435 (2019).","DOI":"10.1002\/ejhf.1320"},{"key":"46021_CR22","first-page":"H250","volume":"275","author":"P Yue","year":"1998","unstructured":"Yue, P., Massie, B. M., Simpson, P. C. & Long, C. S. Cytokines expression increases in nonmyocytes from rats with postinfarction heart failure. Am. J. Physiol. 275, H250\u2013H258 (1998).","journal-title":"Am. J. Physiol."},{"key":"46021_CR23","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ijcard.2014.10.140","volume":"179","author":"KM Gomes","year":"2015","unstructured":"Gomes, K. M. et al. Aldehydic load and aldehyde dehydrogenase 2 profile during the progression of post-myocardial infarction cardiomyopathy: benefits of Alda-1. Int. J. Cardiol. 179, 129\u2013138 (2015).","journal-title":"Int. J. Cardiol."},{"key":"46021_CR24","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1161\/01.CIR.0000018605.14470.DD","volume":"105","author":"K Nakamura","year":"2002","unstructured":"Nakamura, K. et al. Carvedilol decreases elevated oxidative stress in human failing myocardium. Circulation 105, 2867\u20132871 (2002).","journal-title":"Circulation"},{"key":"46021_CR25","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1007\/s00018-003-3206-5","volume":"61","author":"P Chelikani","year":"2004","unstructured":"Chelikani, P., Fita, I. & Loewen, P. C. Diversity of structures and properties among catalases. Cell. Mol. Life Sci. 61, 192\u2013208 (2004).","journal-title":"Cell. Mol. Life Sci."},{"key":"46021_CR26","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.hlc.2017.11.005","volume":"28","author":"S de Souza Vieira","year":"2019","unstructured":"de Souza Vieira, S. et al. Exercise training potentiates the cardioprotective effects of stem cells post-infarction. Heart Lung Circ. 28, 263\u2013271 (2019).","journal-title":"Heart Lung Circ."},{"key":"46021_CR27","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/S0735-1097(00)00671-9","volume":"36","author":"S Wei","year":"2000","unstructured":"Wei, S., Chow, L. T. & Sanderson, J. E. Effect of carvedilol in comparison with metoprolol on myocardial collagen postinfarction. J. Am. Coll. Cardiol. 36, 276\u2013281 (2000).","journal-title":"J. Am. Coll. Cardiol."},{"key":"46021_CR28","first-page":"5763256","volume":"2018","author":"HA de Oliveira","year":"2018","unstructured":"de Oliveira, H. A. et al. Photobiomodulation leads to reduced oxidative stress in rats submitted to high-intensity resistive exercise. Oxid. Med. Cell. Longev. 2018, 5763256 (2018).","journal-title":"Oxid. Med. Cell. Longev."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-46021-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-46021-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-46021-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T10:57:34Z","timestamp":1671274654000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-46021-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,1]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["46021"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-46021-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,1]]},"assertion":[{"value":"12 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9425"}}